These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9541003)

  • 1. On the target of a novel class of antibiotics, oxazolidinones, active against multidrug-resistant Gram-positive bacteria.
    Burghardt H; Schimz KL; Müller M
    FEBS Lett; 1998 Mar; 425(1):40-4. PubMed ID: 9541003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria.
    Swaney SM; Aoki H; Ganoza MC; Shinabarger DL
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3251-5. PubMed ID: 9835522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors.
    Matassova NB; Rodnina MV; Endermann R; Kroll HP; Pleiss U; Wild H; Wintermeyer W
    RNA; 1999 Jul; 5(7):939-46. PubMed ID: 10411137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes.
    Aoki H; Ke L; Poppe SM; Poel TJ; Weaver EA; Gadwood RC; Thomas RC; Shinabarger DL; Ganoza MC
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1080-5. PubMed ID: 11897593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds.
    Daly JS; Eliopoulos GM; Reiszner E; Moellering RC
    J Antimicrob Chemother; 1988 Jun; 21(6):721-30. PubMed ID: 3410799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro microbiological activities of DuP 105 and DuP 721, novel synthetic oxazolidinones.
    Brumfitt W; Hamilton-Miller JM
    J Antimicrob Chemother; 1988 Jun; 21(6):711-20. PubMed ID: 3137206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxazolidinones: a novel class of antibiotics.
    Müller M; Schimz KL
    Cell Mol Life Sci; 1999 Oct; 56(3-4):280-5. PubMed ID: 11212355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions.
    Shinabarger DL; Marotti KR; Murray RW; Lin AH; Melchior EP; Swaney SM; Dunyak DS; Demyan WF; Buysse JM
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2132-6. PubMed ID: 9333037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis.
    Eustice DC; Feldman PA; Zajac I; Slee AM
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1218-22. PubMed ID: 2461163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of linezolid against multi-resistant gram-positive bacteria from diverse hospitals in the United Kingdom.
    Johnson AP; Warner M; Livermore DM
    J Antimicrob Chemother; 2000 Feb; 45(2):225-30. PubMed ID: 10660506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid is a specific inhibitor of 50S ribosomal subunit formation in Staphylococcus aureus cells.
    Champney WS; Miller M
    Curr Microbiol; 2002 May; 44(5):350-6. PubMed ID: 11927986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxazolidinones: new antibacterial agents.
    Ford CW; Hamel JC; Stapert D; Moerman JK; Hutchinson DK; Barbachyn MR; Zurenko GE
    Trends Microbiol; 1997 May; 5(5):196-200. PubMed ID: 9160508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections.
    Brickner SJ; Hutchinson DK; Barbachyn MR; Manninen PR; Ulanowicz DA; Garmon SA; Grega KC; Hendges SK; Toops DS; Ford CW; Zurenko GE
    J Med Chem; 1996 Feb; 39(3):673-9. PubMed ID: 8576909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin.
    Lin AH; Murray RW; Vidmar TJ; Marotti KR
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2127-31. PubMed ID: 9333036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell-free systems derived from both gram-positive and gram-negative bacteria.
    McNicholas PM; Najarian DJ; Mann PA; Hesk D; Hare RS; Shaw KJ; Black TA
    Antimicrob Agents Chemother; 2000 May; 44(5):1121-6. PubMed ID: 10770739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New oxazolidinones.
    Vara Prasad JV
    Curr Opin Microbiol; 2007 Oct; 10(5):454-60. PubMed ID: 17928263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents.
    Barry AL
    Antimicrob Agents Chemother; 1988 Jan; 32(1):150-2. PubMed ID: 3348606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protected nucleotide G2608 in 23S rRNA confers resistance to oxazolidinones in E. coli.
    Xu J; Golshani A; Aoki H; Remme J; Chosay J; Shinabarger DL; Ganoza MC
    Biochem Biophys Res Commun; 2005 Mar; 328(2):471-6. PubMed ID: 15694371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials.
    Dresser LD; Rybak MJ
    Pharmacotherapy; 1998; 18(3):456-62. PubMed ID: 9620097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.